These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22936447)

  • 1. Claudin expression in breast cancer: high or low, what to expect?
    Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
    Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
    Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
    Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
    Zhou S; Piao X; Wang C; Wang R; Song Z
    Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
    Lin X; Shang X; Manorek G; Howell SB
    PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.
    Tokés AM; Kulka J; Paku S; Szik A; Páska C; Novák PK; Szilák L; Kiss A; Bögi K; Schaff Z
    Breast Cancer Res; 2005; 7(2):R296-305. PubMed ID: 15743508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
    Danzinger S; Tan YY; Rudas M; Kastner MT; Weingartshofer S; Muhr D; Singer CF
    BMC Cancer; 2019 Jul; 19(1):695. PubMed ID: 31307407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
    Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
    Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double mutation of claudin-1 and claudin-3 causes alopecia in infant mice.
    Suzuki K; Yamaga K; Tokumasu R; Katsuno T; Tanaka H; Chiba S; Yagi T; Katayama I; Tamura A; Murota H; Tsukita S
    Ann N Y Acad Sci; 2023 May; 1523(1):51-61. PubMed ID: 37002535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-1, -3, -4 and -7 gene expression analyses in canine prostate carcinoma and mammary tissue derived cell lines.
    Hammer SC; Nagel S; Junginger J; Hewicker-Trautwein M; Wagner S; Heisterkamp A; Ngezahayo A; Nolte I; Murua Escobar H
    Neoplasma; 2016; 63(2):231-8. PubMed ID: 26774145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
    Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
    Front Genet; 2022; 13():783016. PubMed ID: 35281827
    [No Abstract]   [Full Text] [Related]  

  • 16. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
    Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
    Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
    Gerhard R; Ricardo S; Albergaria A; Gomes M; Silva AR; Logullo ÂF; Cameselle-Teijeiro JF; Paredes J; Schmitt F
    Breast; 2012 Jun; 21(3):354-60. PubMed ID: 22464177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
    Shang X; Lin X; Alvarez E; Manorek G; Howell SB
    Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
    Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
    Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.